UBS AG - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 35 filers reported holding CANCER GENETICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AG ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2014$13,000
-18.8%
1,4000.0%0.00%
Q2 2014$16,000
-42.9%
1,400
-25.6%
0.00%
Q1 2014$28,000
+3.7%
1,881
-6.2%
0.00%
Q4 2013$27,000
+800.0%
2,006
+1408.3%
0.00%
Q3 2013$3,0001330.00%
Other shareholders
CANCER GENETICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 581,200$1,157,0001.33%
Fairbanks Capital Management, Inc. 233,170$464,0000.56%
DIKER MANAGEMENT LLC 29,815$59,0000.02%
SABBY MANAGEMENT, LLC 199,580$397,0000.02%
Sterneck Capital Management, LLC 14,750$29,0000.02%
Spot Trading L.L.C 151,900$302,0000.01%
Acrospire Investment Management LLC 3,514$7,0000.01%
EAGLE GLOBAL ADVISORS LLC 84,320$168,0000.01%
BECK MACK & OLIVER LLC 18,225$36,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 47,600$94,0000.00%
View complete list of CANCER GENETICS INC shareholders